AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 JAN 21 - (NewsRx.com & NewsRx.net) -- Researchers have constructed and characterized a candidate HIV-1 subtype C DNA vaccine for South Africa.
"A candidate DNA vaccine pTHgagC expressing the immunodeficiency virus-1 (HIV-1) gag gene from South African isolate Du422 was constructed and characterized. The isolate was selected on the basis of being the closest to the South African subtype C consensus sequence. Sequence analysis of cytotoxic T lymphocyte (CTL) epitopes showed that HIV subtype C-infected individuals have CTL responses to a number of epitopes present in the vaccine, but also revealed a more limited presence of subtype A- and any B-derived epitopes," investigators in South Africa report.
"A high level of expression of the immunogen was demonstrated in human cells and a potent, long-lived CTL response to a single inoculation of the DNA vaccine was elicited in BALB/c mice, which could be significantly increased by a boost vaccination at four weeks," said Joanne H. van Harmelen and collaborators at the University of Cape Town in South Africa and the Weatherall Institute of Molecular Medicine in ...
Source: HighBeam Research, Candidate HIV-1 subtype C DNA vaccine for South Africa characterized.